Medtronic diabetes warning letter lifted by FDA

Medtronic diabetes warning letter lifted by FDA

Source: 
Medtech Dive
snippet: 

Two years after hitting Medtronic with a warning letter for product safety problems with its diabetes group, the Food and Drug Administration lifted the warning on Tuesday.

The regulatory change allows Medtronic to bring products to market in the U.S. more quickly, ending a period of delay for the company.